Different Gm allotype amounts in human intravenous immunoglobulin (IVIG) preparations; survival of foreign Gm allotypes in immunodeficient patients

Clinical and Experimental Immunology

Volumn 106, Issue 2, 1996, Pages 203-207

  Oxelius, V A ^a   Eibl, M M ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gm allotype half lives; Gm allotype quantities; IVIG

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HALF LIFE TIME; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; PRIORITY JOURNAL;

EID: 0029823278     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-851.x     Document Type: Article

References (17)

1. Eibl MM, Wedgwood RJ, Intravenous immunoglobulin. In: Rosen FS, Seligmann M, eds. Immunodeficiencies. Chur, Switzerland: Harwood Academic Publishers, 1993:659 88.
2. Römer J, Späth PJ, Skvaril F, Nydegger UE. Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to Staphylococcus protein A. Vox Sang 1982; 42:74 80.
3. Burckhardt JJ, Gardi A, Oxelius V-A, Preud'homme J-L, Scherz R, Skvaril F, Heiniger H-J. Immunoglobulin G subclass distribution in three human intravenous immunoglobulin preparations. Vox Sang 1989; 57:10 14.
4. Schiff RI, Rudd C. Alterations in the half-lives and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency J Clin Immunol 1986; 6:256 64.
5. Mankarious S, Lee M, Fischer S, Pyun KH, Ochs HD, Oxelius V-A, Wedgwood RJ. The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who received intravenously administered immunoglobulin. J Lab Clin Invest 1988; 49:673 80.
6. Fischer SH, Ochs HD, Wedgwood RJ, Skvaril F, Morell A, Hill HR, Sehiffman G, Corey L. Survival of antigen-specific, antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases. Monographs in Allergy 1988; 23:225 35.
7. Wedgwood RJ. The distribution and catabolism of IVIG preparations in immunodeficient patients. In: Imbach P. ed. Immunotherapy with intravenous immunoglobulins. New York: Academic Press, 1991:17 45.
8. Grubb RE. Human immunoglobulin allotypes and Mendelian polymorphism of human immunoglobulin genes. In: Oss CJ, Regenmortel MHV, eds, Immunochemistry. New York: Marcel Dekker, 1994:47 68.
9. Oxelius V-A, Carlsson A-M. Quantitation of Gm allotypes. Scand J Immunol 1993; 37:143 8.
10. Oxelius V-A. Serum IgG and IgG subclass contents in different Gm phenotypes. Scand J Immunol 1993; 37:149 53.
11. Oxelius V-A. Lack of G2m(n) allotype in IgG subclass deficiency, in IgG2 deficiency together with lack of G1m(a) and G3m(g) and in IgG3 deficiency together with lack Of G1m(f) and G3m(b). Scand J Immunol 1990; 31:243 7.
12. Oxelius V-A, Carlsson A-M, Hammarström L, Björkander J, Hanson LÅ. Linkage of IgA deficiency to Gm allotypes; the influence of Gm allotypes on IgA-IgG subclass deficiency. Clin Exp Immunol 1995; 99:211 5.
13. Oxelius V-A. Suppressed G2m(n) levels from IGHCG2 in IgA deficiency. Exp Clin Immunogenet 1996; 13:1 6.
14. Rautonen N, Seppälä I, Hallberg T, Grubb R, Mäkälä O. Determination of homozygosity or heterozygosity for the G2m(n) allotype by a monoclonal precipitating antibody. Exp Clin Immunogenet 1989; 6:31 37.
15. Jungi TW, Eiholzer J, Lerch PG, Barandun S. The capacity of various types of immunoglobulin for intravenous use to interact with Fc receptors of human monocytes and macrophages. Blut 1986; 53:321 32.
16. Dwyer JM. Manipulating the immune system with immune globulin. New Engl J Med 1992; 326:107 16.
17. Pandey J, Fudenberg HH, Virella G, Kyong C, Loadholt C, Galbraith R, Gotschlich EC, Parke JC. Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and meningococcus polysacharides. Lancet 1979; i:190 2.